CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Principles for Deliberative Processes in Health Technology Assessment

August 17, 2020
Deliberative processes in health technology assessment (HTA) were the focus of the 2020 HTAi Global Policy Forum; this new article summarizes the discussions that were held over two days in January. Dr. Nicole Mittmann, Chief Scientist and Vice-President of Evidence Standards at CADTH, was one of eighty participants from 22 countries who attende...

CADTH Welcomes Suzanne McGurn as President and CEO

July 6, 2020
CADTH is proud to welcome Suzanne McGurn, who begins her role as President and Chief Executive Officer today. Ms. McGurn was appointed by the CADTH Board of Directors after a comprehensive search that was international in scope. She brings to CADTH significant leadership experience and a deep understanding of the diverse needs of governmen...

CADTH Pharmaceutical Reviews Update — Issue 16

June 26, 2020
See Pharmaceutical Reviews Update – Issue 16 for important news and information related to CADTH’s drug review programs. Highlights from this issue include: a consultation on CADTH’s drug reimbursement review procedures a consultation on the Health Canada, CADTH, and INESSS aligned review process changes to the prov...